相关实验视频
Updated: Jun 14, 2025

06:19
The Mouse Forced Swim Test
Published on: January 29, 2012
105.2K
抗抑郁药和COVID-19:使用量增加,在水中发生,对水生环境的影响和后果. 一个审查审查
Antón Puga1, Manuela M Moreira2, M Angeles Sanromán3
1REQUIMTE/LAQV, Instituto Superior de Engenharia do Porto, Instituto Politécnico do Porto, Rua Dr. António Bernardino de Almeida, 431, 4249-015 Porto, Portugal; CINTECX, University of Vigo, BIOSUV Group, Department of Chemical Engineering, Campus Lagoas-Marcosende, 36310 Vigo, Spain.
The Science of the total environment
|September 7, 2024
概括
在全球范围内,COVID-19大流行改变了抗抑郁药的使用. 本次审查强调了消费和检测的增加,强调迫切需要对这些广泛使用的药物进行水生环境影响研究.
科学领域:
- 环境化学环境化学
- 药理学 药理学是指药理学的学科.
- 生态毒理学 生态毒理学
背景情况:
- COVID-19 流行病对全球药物消费模式产生了重大影响,抗抑郁药物显示出显著的变化.
- 了解抗抑郁药使用的转变对于评估潜在的环境影响至关重要.
研究的目的:
- 为了评估COVID-19大流行之前和之后抗抑郁药消费频率的变化.
- 为了识别广泛消费和检测到的抗抑郁药,其生命周期,代谢物和环境发生.
- 审查抗抑郁药对水生生物的影响,并确定研究缺口.
主要方法:
- 对抗抑郁药消费趋势在COVID-19之前和之后的文献进行系统审查.
- 对抗抑郁药物检测,生命周期和各种环境组件中的代谢物存在的数据的分析.
- 对抗抑郁药对水生生物的生态毒理学影响的研究的汇编和评估.
主要成果:
- 抗抑郁药的消费模式在各大洲的流行后变化.
- 确定了关键的抗抑郁药,并对其检测频率和代谢物进行了调查.
- 许多普遍存在的抗抑郁药物对环境发生和水生有毒性的研究存在重大差距.
结论:
- 进一步的研究是必要的,以了解经常处方抗抑郁药的环境命运和影响.
- 优先研究流行后抗抑郁药在水生生态系统中的发生和不良影响至关重要.
相关概念视频
Antidepressant Drugs: Overview
389
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
389
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
335
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
335
Antidepressant Drugs: MAOIs and Other Agents
205
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
205
Drug Therapy
40
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
40
Electroconvulsive Therapy
29
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
29
Depression: Overview
228
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
228

